Product Description
Ipratropium Bromide Aerosol, Western medicine name. For bronchodilators. Asthma for chronic asthmatic bronchitis. It is characterized by less irritation, no irritating cough after spraying, and obvious effect on relieving asthma and suffocation. Sputum is easier to expectorate after inhalation of this product.
Element
The main ingredient of this product is ipratropium bromide.
Chracteristic
This product is colorless or light yellow clear liquid; it has a mellow odor.
Indications
This product is used to relieve asthma of chronic asthmatic bronchitis. It is characterized by less irritation, no irritating cough after spraying, and obvious effect on relieving asthma and suffocation. Sputum is easier to expectorate after inhalation of this product.
Specification
Each bottle of 14g contains 8.4mg of ipratropium bromide.
Dosage
Spray inhalation, 40μg per squeeze, 1-2 squeezes at a time, 2-3 times a day if necessary. When using, first remove the cap of the cover, turn the bottle upside down, put the cover in the mouth, aim at the throat, press the nozzle on the valve while inhaling, inhale the sprayed liquid medicine, and hold your breath for a while. If necessary, repeat the above inhalation once more.
Clinical application and guidelines
1. A Xuande et al. studied the clinical efficacy of Jinshuibao capsule combined with ipratropium bromide aerosol in the treatment of acute exacerbation of chronic obstructive pulmonary disease, and concluded that Jinshuibao capsule combined with ipratropium bromide aerosol in the treatment of chronic obstructive pulmonary disease The acute exacerbation of STD has good clinical curative effect, can significantly improve the clinical symptoms and lung function of patients, has high safety, and has certain clinical application value. (Modern Medicine and Clinical, 2018, 33(09):2290-2293.)
2. Cong Meijiao studied the value of combined use of salbutmol aerosol and ipratropium bromide aerosol in the treatment of chronic obstructive pulmonary disease, and concluded that in the treatment of chronic obstructive pulmonary disease, combined use of albuterol aerosol And ipratropium bromide aerosol has exact curative effect and good safety, which can be promoted. (Chinese Medicine Guide, 2018, 16(14):97.)
Adverse reactions
Except for dry mouth after inhalation, no other side effects were found.
Taboo
1. This product is prohibited for those allergic to soybean lecithin or related foods such as soybeans and peanuts. These patients can use other dosage forms of aerosol inhalers that do not contain soy lecithin.
2. Those who are allergic to atropine or its derivatives or other ingredients of this product are prohibited.
Precautions
Glaucoma, prostatic hypertrophy and patients with allergies to this product are hanged.
medicine interactions
Drug interactions may occur if used concomitantly with other drugs, please consult your physician or pharmacist for details.
pharmacological action
This product is an anticholinergic bronchodilator, which has anti-asthmatic effect on asthmatic chronic bronchitis, and has a certain curative effect, especially the relaxation effect of the trachea is obvious, the effect is fast, the duration is long, and the side effects are small. In addition, this product also has the effect of controlling the secretion of mucous glands and improving the movement of cilia, thereby reducing sputum obstruction to improve ventilation, and reducing sputum also reduces bronchospasm caused by irritation to the bronchi. Compared with β-adrenergic receptor stimulants (such as isoproterenol), this product has less cardiovascular side effects. The amount of regulation is strong.
Storage
Shade and store in a cool place (not more than 20ºC).
Audited Supplier 
){kind=link}